IU

INSERM U633 "Cell therapy in cardiovascular diseases"

Technology Company

Worked at INSERM U633 "Cell therapy in cardiovascular diseases"

MP

Mathieu Pieronne

Director, venture capital life sciences at Andera Partners

All information is sourced from public domain and might be inaccurate.